Nanotechnology increasingly used in medical devices The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.
Greater influx of migrants not expected to lead to an increase in cases of tuberculosis According to the RIVM report ‘Tuberculosis in the Netherlands 2014’, a total of 823 people were diagnosed with TB last year. That is 21 fewer patients than in 2013.
Replacement possible for products with carcinogenic formaldehyde There seem to be sufficient alternatives available for the majority of disinfectants and preservatives containing the carcinogenic substance formaldehyde.
WHO’s first ever global estimates of foodborne diseases: children under five account for almost one third of deaths Almost one third (30%) of all deaths from foodborne diseases are in children under the age of five years, despite the fact that they make up only 9% of the global population.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.
Breast milk as indicator of environmental pollutants The 6th worldwide study into Persistent Organic Pollutants (POPs) in breast milk is about to commence.
The National Immunisation Programme in the Netherlands: Developments in 2013 Annually RIVM provides an overview of key events and developments in the National Immunisation Programme (NIP).
ICP M&M meetings in 2012 The 22nd CCE workshop 2012 and 28th Task Force Meeting of the ICP M&M are held 16-19 April 2012 in Warsaw, Poland
No evidence for zoonotic infection caused by Schmallenbergvirus In total, 301 persons were tested for antibodies to Schmallenberg virus by virus neutralization test.